Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 7122

People who are sick can ask for EUA drugs, but you have to ask often. INDIANAPOLIS, Nov. 9, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for Eli Lilly and Company’s (NYSE: LLY) investigational neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. Bamlanivimab is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test, who are at high risk for progressing to severe COVID-19 and/or hospitalization. Bamlanivimab should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion.

The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial analysts.

Read more | >

Baxter International Inc. (NYSE: BAX), a global leader in acute care, recognizes the findings of a prospective, multicenter, observational study on data from the OxirisNet Registry evaluating severely ill patients with COVID-19 in Italy treated with extracorporeal (outside the body) blood purification (EBP) using the company’s Oxiris filter set. From the study, recently published in Critical Care, the investigators reported that patients experienced a significant reduction in serum IL-6 (a pro-inflammatory cytokine) levels, improvement in indicators of organ dysfunction and reduction in expected intensive care unit (ICU) mortality rate as compared to a historical control. Due to the study design, the results do not provide evidence of a causal relationship between EBP treatment with Oxiris and these outcomes. The results do, however, support the feasibility of the use of Oxiris with severely ill COVID-19 patients and provide new insights for clinicians treating this vulnerable patient population.

Study investigators assessed serum IL-6 levels, indicators of organ dysfunction and intensive care unit (ICU) mortality rate in patients undergoing EBP with Oxiris.

Read more | >

A standard test that evaluates blood cells can help identify patients hospitalized with COVID-19 who are at an elevated risk for death, according to research published in JAMA Network Open.

“We were surprised to find that one standard test that quantifies the variation in size of red blood cells — called red cell distribution width, or RDW — was highly correlated with patient mortality, and the correlation persisted when controlling for other identified risk factors like patient age, some other lab tests, and some pre-existing illnesses,” Jonathan Carlson, MD, PhD, an instructor in medicine at Massachusetts General Hospital, said in a press release.

In their cohort study, Carlson and colleagues retrospectively analyzed adult patients with SARS-CoV-2 infection who were admitted to one of four participating hospitals in the Boston area from March 4 through April 28. As part of standard critical care, all patients had their RDW, absolute lymphocyte count and dimerized plasmin fragment D levels collected daily.

Read more | >
2020 GEO SDG Award for CirroLytix

MANILA, Philippines — A Filipino startup is recognized globally in developing a dengue hotspot prediction system using satellite and climate data in the 2020 Group on Earth Observations Sustainable Development Goals (GEO SDG) Awards for the Sectoral category, For-Profit. The GEO SDG Awards recognize the productivity, ingenuity, proficiency, novelty, and exemplary communications of results and experiences in the use of Earth observations to support sustainable development.

CirroLytix Research Services was formed to create social impact through big data. Through the application of machine learning, data engineering, remote sensing, and social listening, the Philippines-based data analytics firm hopes to help governments, researchers, non-government organizations (NGO), and social enterprises achieve positive change. The Advanced Early Dengue Prediction and Exploration Service (Project AEDES) is one of the CirroLytix’s flagship projects developed during the 2019 National Aeronautics and Space Administration’s (NASA) International Space Apps Challenge. It combines digital, climate, and remote sensing to nowcast dengue trends and detect mosquito habitats to help pre-empt cases of dengue. Project AEDES process leverages normalized difference vegetation index (NDVI), Fraction of absorbed photosynthetically active radiation (FAPAR), and normalized difference water index (NDWI) readings from Landsat and Sentinel-2 to estimate still water areas on the ground, which is correlated with dengue case counts from national health centers.

The Advanced Early Dengue Prediction and Exploration Service (Project AEDES) combines digital, climate, and remote sensing to nowcast dengue trends and detect mosquito habitats to help pre-empt cases of dengue.
Continue reading “Filipino startup recognized in addressing SDG’s using space tech” | >

Astronomers behind the most extensive search yet for alien life are investigating an intriguing radio wave emission that appears to have come from the direction of Proxima Centauri, the nearest star to the sun.

The narrow beam of radio waves was picked up during 30 hours of observations by the Parkes telescope in Australia in April and May last year, the Guardian understands. Analysis of the beam has been under way for some time and scientists have yet to identify a terrestrial culprit such as ground-based equipment or a passing satellite.

Read more | >

India just laid the foundations for what officials are claiming will be the world’s largest renewable energy park. The gigantic project, in the Kutch region of western Gujarat, will cover an area of 180, 000 acres — an area roughly the size of Singapore, as Agence France-Presse reports.

Once finished, the park will produce 30 gigawatts of electricity from both wind turbines and solar arrays, thereby cutting carbon dioxide emissions by up to 50 million tons per year. For perspective, the protagonists in the 1985 film “Back to the Future” needed to generate a staggering 1.21 gigawatts of power to activate their time machine — and this new facility will produce more than 24 times that figure.

“The hybrid renewable energy park will be largest in the world and generate 30, 000 megawatts of power,” prime minister Narendra Modi said during the park’s official inauguration, according to AFP.

Read more | >